Online Post Tests – Johns Hopkins Medicine – Office of Continuing Medical Education

2009 : Online Post Tests – Johns Hopkins Medicine – Office of Continuing Medical Education

• eNeonatal Review Podcasts
  • eNeonatal Podcast (Vol. 5, No. 10) – June 2008
  • eNeonatal Podcast (Vol. 5, No. 12) – August 2008
  • eNeonatal Podcast (Vol. 5, No. 5) – January 2008
  • eNeonatal Podcast (Vol. 5, No. 7) – March 2008
  • eNeonatal Podcast (Vol. 5, No. 8) – April 2008
  • eNeonatal Podcast (Vol. 6, No. 2) – October 2008
  • eNeonatal Podcast (Vol. 6, No. 7) – March 2009

• eTransplant Review
  • eTransplantID Review (Volume 1, Number 1) – March 2009
  • eTransplantID Review (Volume 1, Number 2) – April 2009
  • eTransplantID Review (Volume 1, Number 3) – May 2009

• eTransplantID Review Podcasts
  • eTransplantID Review Podcast (Volume 1, Number 2)

• JHU ID Grand Rounds
  • JHU ID Rounds Case 018 (80016862)
  • JHU ID Rounds Case 013 (80016862)
  • JHU ID Rounds Case 001 (80016862)
  • JHU ID Rounds Case 002 (80016862)
  • JHU ID Rounds Case 003 (80016862)
  • JHU ID Rounds Case 004 (80016862)
  • JHU ID Rounds Case 005 (80016862)
  • JHU ID Rounds Case 006 (80016862)
  • JHU ID Rounds Case 007 (80016862)
  • JHU ID Rounds Case 008 (80016862)
  • JHU ID Rounds Case 009 (80016862)
  • JHU ID Rounds Case 010 (80016862)
  • JHU ID Rounds Case 011 (80016862)
  • JHU ID Rounds Case 012 (80016862)
  • JHU ID Rounds Case 014 (80016862)
  • JHU ID Rounds Case 020 (80016862)
  • JHU ID Rounds Case 015 (80016862)
  • JHU ID Rounds Case 016 (80016862)
  • JHU ID Rounds Case 017 (80016862)
  • JHU ID Rounds Case 026 (80016862)
  • JHU ID Rounds Case 019 (80016862)
  • JHU ID Rounds Case 046 (80016862)
  • JHU ID Rounds Case 021 (80016862)
  • JHU ID Rounds Case 022 (80016862)
  • JHU ID Rounds Case 023 (80016862)
  • JHU ID Rounds Case 024 (80016862)
  • JHU ID Rounds Case 025 (80016862)
  • JHU ID Rounds Case 027 (80016862)
  • JHU ID Rounds Case 028 (80016862)
  • JHU ID Rounds Case 039 (80016862)
  • JHU ID Rounds Case 029 (80016862)
  • JHU ID Rounds Case 030 (80016862)
  • JHU ID Rounds Case 031 (80016862)
  • JHU ID Rounds Case 032 (80016862)
  • JHU ID Rounds Case 033 (80016862)
  • JHU ID Rounds Case 035 (80016862)
  • JHU ID Rounds Case 034 (80016862)
  • JHU ID Rounds Case 036 (80016862)
  • JHU ID Rounds Case 037 (80016862)
  • JHU ID Rounds Case 038 (80016862)
  • JHU ID Rounds Case 044 (80016862)
  • JHU ID Rounds Case 040 (80016862)
  • JHU ID Rounds Case 041 (80016862)
  • JHU ID Rounds Case 042 (80016862)
  • JHU ID Rounds Case 043 (80016862)
  • JHU ID Rounds Case 048 (80016862)
  • JHU ID Rounds Case 045 (80016862)
  • JHU ID Rounds Case 050 (80016862)
  • JHU ID Rounds Case 047 (80016862)
  • JHU ID Rounds Case 052 (80016862)
  • JHU ID Rounds Case 049 (80016862)
  • JHU ID Rounds Case 054 (80016862)
  • JHU ID Rounds Case 051 (80016862)
  • JHU ID Rounds Case 056 (80016862)
  • JHU ID Rounds Case 053 (80016862)
  • JHU ID Rounds Case 058 (80016862)
  • JHU ID Rounds Case 055 (80016862)
  • JHU ID Rounds Case 060 (80016862)
  • JHU ID Rounds Case 057 (80016862)
  • JHU ID Rounds Case 062 (80016862)
  • JHU ID Rounds Case 059 (80016862)
  • JHU ID Rounds Case 064 (80016862)
  • JHU ID Rounds Case 061 (80016862)
  • JHU ID Rounds Case 066 (80016862)
  • JHU ID Rounds Case 063 (80016862)
  • JHU ID Rounds Case 068 (80016862)
  • JHU ID Rounds Case 065 (80016862)
  • JHU ID Rounds Case 070 (80016862)
  • JHU ID Rounds Case 067 (80016862)
  • JHU ID Rounds Case 072 (80016862)
  • JHU ID Rounds Case 069 (80016862)
  • JHU ID Rounds Case 078 (80016862)
  • JHU ID Rounds Case 071 (80016862)
  • JHU ID Rounds Case 073 (80016862)
  • JHU ID Rounds Case 074 (80016862)
  • JHU ID Rounds Case 075 (80016862)
  • JHU ID Rounds Case 076 (80016862)
  • JHU ID Rounds Case 077 (80016862)
  • JHU ID Rounds Case 081 (80016862)
  • JHU ID Rounds Case 079 (80016862)
  • JHU ID Rounds Case 080 (80016862)
  • JHU ID Rounds Case 082 (80016862)
  • JHU ID Rounds Case 088 (80016862)
  • JHU ID Rounds Case 083 (80016862)
  • JHU ID Rounds Case 085 (80016862)
  • JHU ID Rounds Case 086 (80016862)
  • JHU ID Rounds Case 087 (80016862)
  • JHU ID Rounds Case 091 (80016862)
  • JHU ID Rounds Case 089 (80016862)
  • JHU ID Rounds Case 090 (80016862)
  • JHU ID Rounds Case 092 (80016862)
  • JHU ID Rounds Case 093 (80016862)

• Johns Hopkins Rheumatology Rounds Online
  • An old paradigm revisited The case of a 29-year-old woman with painful, blue digits presented by Gordon Lam
  • Autoimmunity through Cytokine-Induced Dendritic Cell Activation presented by Virginia Pascual, MD
  • Facial Swelling presented by Christopher V. Tehlirian, MD (80021421)
  • Lupus and Complement Deficiency Insights from Knockout Mice presented by Marina Botto (80021421)
  • Rheumatoid Lung Disease presented by Christopher V. Tehlirian, MD (80021421)
  • Why a Rheumatologist needs to Understand Uveitis presented by James Rosenbaum

• Management of AMD
  • Management of AMD Current Evidence on Treatment of CNV
  • Management of AMD Alternative Therapies for CNV
  • Management of AMD Follow-up After Initiating Treatment for CNV in AMD
  • Management of AMD Impact of AMD and Treatment on Quality of Life
  • Management of AMD Introduction Magnitude of the Problem
  • Management of AMD Managing Patient and Physician Expectations
  • Management of AMD Monitoring for Progression to CNV
  • Management of AMD The Use of Dietary Supplements as Those Used in AREDS

• Maximizing Success While Preserving Future Options
  • Selecting PI in PI-Naive Patient
  • Challenges in the Management of Pre-existing Antiretroviral Resistance
  • Approach to the Patient with Multiclass Antiviral Resistance
  • Maximizing Success and Preserving Future Options in a Minority Population
  • Maximizing Success While Preserving Future Options Debating Antiretroviral Treatment Options (Roundtable Discussion)
  • Selecting a PI in a PI-Experienced Patient
  • Use of Newer Antiretrovirals in Treatment Naive Patients
  • Maximizing Success While Preserving Future Options Debating Antiretroviral Treatment Options

• Rheumatic Disease Update 2007
  • Cardiovascular Risk in the Rheumatic Diseases presented by Jon Giles, MD (80016865)
  • Gene Expression Profiling in Rheumatology presented by Felipe Andrade, MD, PhD (80016865)
  • Hepatitis C, Cryoglobulins, and Vasculitis presented by Stuart M. Levine, MD (80016865)
  • Maximizing Patient Outcomes presented by Susan Bartlett, PhD (80016865)
  • Nephrology for the Rheumatologist presented by Derek Fine, MD (80016865)
  • Non-Scleroderma-Like Fibrosing Disorders of the Skin presented by Francesco Boin, MD (80016865)
  • NSAIDS and Cardiovascular Risk presented by Dan Solomon, MD, MPH (80016865)
  • Ocular Inflammation presented by George B. Peters III, MD, MBA (80016865)
  • Osteoarthritis Emerging Therapeutic Options presented by Clifton O. Bingham III, MD (80016865)
  • Osteoporosis Update presented by Michele Bellantoni, MD (80016865)
  • Phenotypic Expression of Chronic Inflammation presented by Joan M. Bathon, MD (80016865)
  • Psoriatic Arthritis An Update presented by Christopher Ritchlin, MD (80016865)
  • Rheumatoid Arthritis Update on Biological Therapy presented by Michael Weinblatt, MD (80016865)
  • Statin Myopathy presented by Lisa Christopher-Stine, MD (80016865)
  • The Evaluation of Eosinophilia presented by Bruce Bochner, MD (80016865)
  • Update in the Management of Juvenile Chronic Polyartharitis presented by Sangeeta Sule, MD (80016865)
  • Vasculitis presented by Gary Hoffman, MD, MS (80016865)

• Sleep University
  • Recognizing and Treating Insomnia
  • Sleep University Webinar
  • The Art of Sleep Recognizing and treating insomnia in primary care practice

• Solving the Complexities of Treating Antiretroviral-Experienced Patients
  • Solving the Complexities of Treating Antiretroviral-Experienced Patients

• The American Journal of Hematology Oncology
  • Adjuvant chemotherapy and radiation following pancreaticoduodenectomy for pancreatic adenocarcinoma Summary of trials and future directions
  • Efficacy and safety of everolimus in metastatic renal cell carcinoma
  • MRI identifies secondary breast cancers in patients eligible for partial breast irradiation (PBI)
  • Preoperative therapy for patients with resectable adenocarcinoma of the pancreatic head
  • Survival after high-dose therapy and autologous transplantation for patients with chemoresistant Hodgkin lymphoma

Sous total 1er jour : 40 crédits

Sous total 2eme jour : 44 crédits.

Sous total 3ème jour : 48 crédits. (soit une démonstration d’une croissance de 10% par jour)

Total final : 132 AMA PRA Category 1 Credit™

Temps : 3 jours (du 29 au 31 décembre 2009)

source : http://geffrotin.com/yann/cv/education_CME.php?lang=FR

http://geffrotin.com/yann/cv/

http://www.gettyimages.com/detail/rbrs_0190/Digital-Vision

Johns Hopkins Advanced Studies in Medicine (JHASIM)

2009 : Online Post Tests – Johns Hopkins Medicine – Office of Continuing Medical Education

• 16th Conference on Retroviruses and Opportunistic Infections
  • Initiating and Improving ARV Therapy Debating the Data, Reviewing the Options
  • Archived Internet Symposium From the 16th Conference on Retroviruses
  • Newsletter of Conference Coverage From the 16th Conference on Retroviruses and Opportunistic Infections

• Clinical Challenges in the Management of Metastatic Colorectal Cancer
  • Clinical Challenges in the Management of Metastatic Colorectal Cancer

• Current Perspectives and Future Trends in the Treatment of HIV Infection
  • Current Perspectives and Future Trends in the Treatment of HIV Infection

• eCysticFibrosis Review Newsletter
  • eCysticFibrosis Review (Vol. 1, No. 1) – May 2008
  • eCysticFibrosis Review (Vol. 1, No. 2) – July 2008
  • eCysticFibrosis Review (Vol. 1, No. 3) – September 2008
  • eCysticFibrosis Review (Vol. 1, No. 4) – November 2008
  • eCysticFibrosis Review (Vol. 1, No. 6) – March 2009
  • eCysticFibrosis Review (Vol. 1, No. 5) – January 2009

• eCysticFibrosis Review Podcast
  • eCysticFibrosis Review Podcast (Vol. 1, No. 4) – November 2008
  • eCysticFibrosis Review Podcast (Vol. 1, No. 3) – September 2008
  • eCysticFibrosis Review Podcast (Vol. 1, No. 5) – January 2009

• Educational Alliance for Consensus on Treatment-Resistant Depression – Performance Improvement Training Webinar
  • Educational Alliance for Consensus on Treatment-Resistant Depression

• Educational Initiative on Constipation Focusing on IBS-C and Chronic Constipation
  • Educational Initiative on Constipation Focusing on IBS-C and Chronic Constipation

• eInfections Review Newsletter
  • eInfections Review (Vol. 1, No. 10) – April 2008
  • eInfections Review (Vol. 1, No. 11) – May 2008
  • eInfections Review (Vol. 1, No. 12) – June 2008
  • eInfections Review (Vol. 1, No. 9) – March 2008
  • eInfections Review (Vol. 1, No. 8) – February 2008

• eInfections Review Podcast
  • eInfections Review Podcast (Vol. 1, No. 12) – June 2008
  • eInfections Review Podcast (Vol. 1, No. 8) – February 2008

• eMedicalDermatology Review
  • eMedicalDermatology Review (Vol. 1, No. 10) – October 2008
  • eMedicalDermatology Review (Vol. 1, No. 11) – December 2008
  • eMedicalDermatology Review (Vol. 1, No. 6) – February 2008
  • eMedicalDermatology Review (Vol. 1, No. 12) – April 2009
  • eMedicalDermatology Review (Vol. 1, No. 7) – April 2008
  • eMedicalDermatology Review (Vol. 1, No. 8) – June 2008
  • eMedicalDermatology Review (Vol. 1, No. 9) – August 2008

• eMedicalDermatology Review Podcasts
  • eMedicalDermatology Review Podcast (Vol. 1, No. 10) – October 2008
  • eMedicalDermatology Review Podcast (Vol. 1, No. 11) – December 2008
  • eMedicalDermatology Review Podcast (Vol. 1, No. 7) – April 2008
  • eMedicalDermatology Review Podcast (Vol. 1, No. 6) – February 2008

• eNeonatal Review
  • eNeonatal Review (Vol. 5, No. 10) – June 2008
  • eNeonatal Review (Vol. 5, No. 11) – July 2008
  • eNeonatal Review (Vol. 5, No. 12) – August 2008
  • eNeonatal Review (Vol. 5, No. 5) – January 2008
  • eNeonatal Review (Vol. 5, No. 6) – February 2008
  • eNeonatal Review (Vol. 5, No. 7) – March 2008
  • eNeonatal Review (Vol. 5, No. 9) – May 2008
  • eNeonatal Review (Vol. 5, No. 8) – April 2008
  • eNeonatal Review (Vol. 6, No. 1) – September 2008
  • eNeonatal Review (Vol. 6, No. 3) – November 2008
  • eNeonatal Review (Vol. 6, No. 2) – October 2008
  • eNeonatal Review (Vol. 6, No. 4) – December 2008
  • eNeonatal Review (Vol. 6, No. 6) – February 2009
  • eNeonatal Review (Vol. 6, No. 5) – January 2009
  • eNeonatal Review (Vol. 6, No. 7) – March 2009
  • eNeonatal Review (Vol. 6, No. 9) – May 2009
  • eNeonatal Review (Vol. 6, No. 8) – April 2009

2009 : Wilmer Eye Institute – Johns Hopkins Advanced Studies in Ophthalmology (JHASIO)

• Enhancing Adherence with Glaucoma Therapy Practical Strategies for Superior Outcomes
• Global Perspectives on Diabetic Retinopathy More Than Meets the Eye
• New Insights in Macular Edema Understanding and Evaluating Treatment Strategies
• New Insights on Enhancing Adherence to Topical Glaucoma Medications

2009 : Johns Hopkins Advanced Studies in Medicine (JHASIM)

• Cardiology
  • Optimizing Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention

• Dermatology
  • Advances in Dermatological Care What the Family Physician Needs to Know
  • What Lies Beneath Taking a Deeper Look at Acne and Patient Care Strategies

• Endocrinology Diabetes
  • Prevention and Management of Hypertension in the Diabetic Patient
  • Type 2 Diabetes Mellitus Highlights from the Endocrine Society Annual Meeting
  • Targeting the Pathophysiology of Type 2 Diabetes The Emerging Role of Incretin-Based Therapies

• Interventional Cardiology Electrophysiology
  • Cardiac Resynchronization Novel Therapy for the Failing Heart

• Lung Cancer
  • Highlights from ASCO – New Clinical Developments in Non-Small-Cell Lung Cancer

• Neurology
  • Advances in the Management and Treatment of Multiple Sclerosis
  • Challenging Issues in the Management of Multiple Sclerosis
  • Current Issues and Ongoing Challenges in MS Neurodegeneration July 2009
  • Current Issues and Ongoing Challenges in MS Neurodegeneration Sep 2008
  • Monograph – Perspectives In Central Nervous System Malignancies
  • Effective Management in Early Idiopathic Parkinson’s Disease
  • New Insights Into MS Neurodegeneration And Neuroprotection
  • Podcasts – Perspectives in Central Nervous System Malignancies
  • Understanding the Ramifications of Switching Among AEDs A 2008 Clinical Update

• Oncology Hematology
  • Blood Conservation and Chemotherapy-Induced Anemia From Evidence-Based Guidelines to Clinical Practice
  • Monograph – Perspectives In Central Nervous System Malignancies
  • New Science and Therapeutic Advances in the Treatment of Renal Cell Carcinoma
  • Podcasts – Perspectives in Central Nervous System Malignancies

• Pulmonary Medicine
  • Asthma Management Strategies An Evaluation of Current and Future Developments
  • Optimizing Patient Outcomes Clinical Use of the Cystic Fibrosis Pulmonary Guidelines (Complimentary)
  • Giving New Hope to Patients with COPD Evaluating Optimal Management Strategies
  • Optimizing Patient Outcomes Clinical Use of the Cystic Fibrosis Pulmonary Guidelines

• Surgery
  • Heart Transplant Webcast (Case 1 Managing Transplant Rejection)
  • Heart Transplant Webcast (Case 2 Preventing and Treating Humoral Rejection)
  • Heart Transplant Webcast (Interview Ideal Immunosuppression Regimens and Emerging Treatments)
  • Heart Transplantation Clinical and Scientific Updates Improving Long-term Outcomes

Sous total 1er jour : 30 crédits

Sous total 2eme jour : 33 crédits.

Sous total 3ème jour : 37 crédits. (soit une démonstration d’une croissance de 10% par jour)

Total final :  100 AMA PRA Category 1 Credit™

Temps : 3 jours (du 26 au 28 décembre 2009)

source : http://geffrotin.com/yann/cv/education_CME.php?lang=FR

http://geffrotin.com/yann/cv/

http://www.gettyimages.com/detail/91497375

PS : Pour l’Ophtalmologie, je n’ai pas pu mettre « Medical Student » lors de l’inscription. Donc, la mention « MD » ou « Doctor of Medicine » n’est pas forcément approprié. (Ce peut être une manière de signaler un pré-requis.)

CDC MMWR – Centers for Disease Control and Prevention through the Morbidity and Mortality Weekly Report

Completed courses :

• CDC MMWR Vol.54 No. RR-11 – Guidelines for Identifying and Referring Persons with Fetal Alcohol Syndrome
• CDC MMWR Vol.55 No. RR-16 – A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States
• CDC MMWR Vol.55 No. RR-17 – Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
• CDC MMWR Vol.57 No. RR-01 – Strategies to Improve External Cause-of-Injury Coding in State-Based Hospital Discharge and Emergency Department Data Systems
• CDC MMWR Vol.57 No. RR-03 – Human Rabies Prevention – United States, 2008
• CDC MMWR Vol.57 No. RR-05 – Prevention of Herpes Zoster
• CDC MMWR Vol.57 No. RR-06 – Recommendations for Postexposure Interventions to Prevent Infection with Hepatitis B Virus, Hepatitis C Virus, or Human Immunodeficiency Virus, and Tetanus in Persons Wounded During Bombings and Similar Mass-Casualty Events – United States, 2008
• CDC MMWR Vol.57 No. RR-08 – Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection
• CDC MMWR Vol.57 No. RR-09 – Recommendations for Partner Services Programs for HIV Infection, Syphilis, Gonorrhea, and Chlamydial Infection
• CDC MMWR Vol.58 No. RR-01 – Guidelines for Field Triage of Injured Patients
• CDC MMWR Vol.58 No. RR-04 – Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
• CDC MMWR Vol.58 No. RR-05 – Compendium of Measures to Prevent Disease Associated with Animals in Public Settings, 2009
• CDC MMWR Vol.58 No. RR-06 – Good Laboratory Practices for Molecular Genetic Testing for Heritable Diseases and Conditions
• CDC MMWR Vol.58 No. RR-11 – Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children
• CDC MMWR Vol.58 No. RR-12 – Recommendations for Diagnosis of Shiga Toxin-Producing Escherichia coli Infections by Clinical Laboratories

Total CME = 29.25
Total CME: PHYS = 5.5
Total CECH = 3

Total Cumulé : 37.75 Crédits

Temps : 3 jours (6 au 8 décembre 2009 ; 5 activités par jour)

Source : http://www2a.cdc.gov/CE/AvailableActivities.asp

http://geffrotin.com/yann/cv/education_CME.php

http://www.gettyimages.com/Search/Search.aspx?contractUrl=2&language=en-US&family=creative&p=73497730&assetType=image

School of Medicine – University of Virginia Health System – Office of Continuing Medical Education

Completed courses :

• ADHD Managing the Continuum from Adolescence to Adulthood
• Colorectal Surgery Exploring Minimally Invasive Approaches
• Effectively Treating Obesity-Related Diabetes
• Fibromyalgia From Diagnosis To Treatment
• Healthy Steps to Treating Childhood Obesity
• Helping Patients Quit Smoking
• HIV AIDS From Diagnosis to Treatment
• Living with Advanced Non-Small Cell Lung Cancer
• Low Sexual Desire In Women Breaking The Silence
• Managing Comorbidities of HIV AIDS
• Metastatic Breast Cancer Individualizing Treatment
• Migraine Relieving the Pain
• OCD Improving Diagnosis, Maximizing Treatment
• Pelvic Health Optimizing Care
• Pets and People The Power of the Health Connection
• Prostate Cancer Update Screening And Prevention
• Risk Assessment And Communication
• Understanding The Role Of Folic Acid In Preconception Care
• Vaccine Update Recent Data And Recommendations

Total : 19 AMA PRA Category 1 Credit™

Temps : 3 jours (3 au 5 décembre 2009)

source : http://www.healthsystem.virginia.edu/Internet/cme/

http://geffrotin.com/yann/cv/education_CME.php

http://www.gettyimages.com/Search/Search.aspx?contractUrl=2&language=en-US&family=creative&assetType=image&p=92788225

Examiner la possibilité d’une carrière en médecine

Es ce qu’une carrière médicale est correcte pour moi ?
Quel est le but de la médecine ?
Es ce que je me soucis beaucoup des autres, de leurs problèmes, et de leur douleur?
Es ce que j’aime aider les gens avec mes compétences et mes connaissances?
Es ce que j’aime apprendre, obtenir de nouvelles connaissances ?
Suis-je souvent à creuser plus profondément dans un sujet, que mon professeur n’en a besoin?
Es ce que je comprend la valeur de l’apprentissage au-delà de simplement faire de bonnes notes?
Suis-je intéressé par le fonctionnement du corps humain?
Suis je intrigué par les manières par lesquelles la médecine peut être utilisé pour améliorer la vie?
Qu’es ce que cela me prend de devenir médecin?
A quoi ressemble une carrière en médecine ?
Combien les médecins gagnent et combien d’heures travaillent-ils ?
De quoi à l’air une école de médecine ?
Comment es ce que je choisi la bonne école pour une éducation pré médicale?
Quels sont les critères qui comptent ?
Comment de temps cela prend d’obtenir une formation médicale?

Sources :

http://www.aamc.org/students/considering/careers.htm

http://www.aamc.org/students/applying/msar.htm

http://www.gettyimages.com/Search/Search.aspx?contractUrl=2&language=en-US&family=creative&assetType=image&p=92788224

lesquelles